The company expands to nationwide availability with the addition of the New York State license.
Fellow Health, focused on advancing male reproductive health through patient-centric testing solutions, has received a laboratory permit from the New York State Department of Health (NYSDOH) Clinical Laboratory Evaluation Program (CLEP) along with approval for its post-vasectomy semen analysis (PVSA). This allows Fellow Health to offer its validated PVSA test in New York.
Roughly 500,000 vasectomies are performed in the US each year, yet historically only 30-40% of patients complete the recommended post-procedure PVSA through traditional in-lab testing, according to a release from Fellow Health. “These marginal compliance rates are typically only reached through resource-intensive clinic follow-ups. Fellow Health’s mail-in PVSA kit dramatically improves compliance rates without increasing provider burden, offering a more accessible and patient-friendly path to follow-up care,” reads the release from the company.
The NYSDOH CLEP oversees labs and laboratory-developed tests in New York State to ensure accuracy, reliability, and compliance with public health standards.
“Fellow Health being approved and available for post-vasectomy testing in New York is a big step forward for my patients,” says Joseph P. Alukal, MD, MBA, associate professor of urology at Columbia University and director of men’s health at Columbia/NewYork-Presbyterian, in a release. “While vasectomy is one of the most reliable forms of contraception, failures can occur, which is why we recommend a confirmatory test after the procedure. Fellow Health’s PVSA helps patients in that they can do the test at home. For busy patients, this is a tremendous convenience.”
Fellow Health anticipates submitting its application to New York for its full semen analysis mail-in kit in the near future. The kit is currently available in other states.
ID 144145917 © Tyler Oneill | Dreamstime.com
